Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer
View ORCID ProfileYves Boucher, Jessica M. Posada, Sonu Subudhi, Spencer R. Rosario, Liqun Gu, Ashwin S. Kumar, Heena Kumra, Mari Mino-Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernandez-Del Castillo, Theodore S. Hong, Mikael J. Pittet, View ORCID ProfileRakesh K. Jain
doi: https://doi.org/10.1101/2022.06.09.22275912
Yves Boucher
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Jessica M. Posada
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
2Department of Pathology, Brigham and Women’s Hospital University of Geneva, CH-1211 Geneva, Switzerland
Sonu Subudhi
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Spencer R. Rosario
3Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, University of Geneva, CH-1211 Geneva, Switzerland
Liqun Gu
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Ashwin S. Kumar
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
4Harvard–MIT Division of Health Sciences and Technology, MIT, University of Geneva, CH-1211 Geneva, Switzerland
Heena Kumra
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Mari Mino-Kenudson
5Department of Pathology, University of Geneva, CH-1211 Geneva, Switzerland
Nilesh P. Talele
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Dan G. Duda
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Dai Fukumura
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Jennifer Y. Wo
6Department of Radiation Oncology, University of Geneva, CH-1211 Geneva, Switzerland
Jeffrey W. Clark
7Department of Medicine, University of Geneva, CH-1211 Geneva, Switzerland
David P. Ryan
7Department of Medicine, University of Geneva, CH-1211 Geneva, Switzerland
Carlos Fernandez-Del Castillo
8Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston
Theodore S. Hong
6Department of Radiation Oncology, University of Geneva, CH-1211 Geneva, Switzerland
Mikael J. Pittet
9Department of Pathology and Immunology, University of Geneva, CH-1211 Geneva, Switzerland
10Ludwig Institute for Cancer Research, 1005 Lausanne, Switzerland
11Agora Cancer Research Center, Lausanne, Switzerland
Rakesh K. Jain
1Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston
Posted June 13, 2022.
Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer
Yves Boucher, Jessica M. Posada, Sonu Subudhi, Spencer R. Rosario, Liqun Gu, Ashwin S. Kumar, Heena Kumra, Mari Mino-Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernandez-Del Castillo, Theodore S. Hong, Mikael J. Pittet, Rakesh K. Jain
medRxiv 2022.06.09.22275912; doi: https://doi.org/10.1101/2022.06.09.22275912
Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer
Yves Boucher, Jessica M. Posada, Sonu Subudhi, Spencer R. Rosario, Liqun Gu, Ashwin S. Kumar, Heena Kumra, Mari Mino-Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernandez-Del Castillo, Theodore S. Hong, Mikael J. Pittet, Rakesh K. Jain
medRxiv 2022.06.09.22275912; doi: https://doi.org/10.1101/2022.06.09.22275912
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2970)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12817)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4622)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2943)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (933)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4412)
- Nursing (238)
- Nutrition (652)
- Oncology (2296)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (282)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1200)
- Primary Care Research (503)
- Public and Global Health (7008)
- Radiology and Imaging (1545)
- Respiratory Medicine (921)
- Rheumatology (445)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)